Idogen Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Rolf Ingvar Lennart Karlsson, was filed 28 Dec 2017.
Idogen: what insiders have been doing
Idogen is a listed company. Its directors and officers file their transactions with Finansinspektionen. Idogen has had no insider filing for more than a year; the last one goes back to 28 December 2017.
Our records for Idogen go back to 2017, with 2 purchases and no sales on the open market in total.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
- 2,891 shares@ SEK 4.39100.0% of flowISIN SE0006887386FI:csv-44e3b7f5868fe2194b17Canonical exit: 27 Mar 2018 (T+90)
- 363 shares@ SEK 42.00100.0% of flowISIN SE0009973308FI:csv-aa3874bd71cd60a55cbcCanonical exit: 10 Sept 2017 (T+90)
2 of 2 declarations
About Idogen
Idogen is a company listed on the Stockholm Stock Exchange, specializing in the development of immunological treatments. It focuses on innovative solutions for autoimmune diseases and cancers.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations